Comparing Prognostic Indices for Breast Cancer
Author Information
Author(s): V. Van Belle, J. Decock, W. Hendrickx, O. Brouckaert, S. Pintens, P. Moerman, H. Wildiers, R. Paridaens, M. R. Christiaens, S. Van Huffel, P. Neven
Primary Institution: University Hospitals Leuven
Hypothesis
Does the log odds prognostic index (Lpi) perform better than the Nottingham Prognostic Index (NPI) for predicting disease-free survival in breast cancer patients?
Conclusion
The study concluded that the Lpi does not perform better than the NPI in predicting disease-free survival for breast cancer patients.
Supporting Evidence
- The NPI had a significantly higher concordance index compared to the Lpi.
- 67 patients developed local recurrence and 193 developed distant metastasis during the follow-up period.
- The study included only patients without prior pathologic sentinel lymph node evaluation.
Takeaway
This study looked at two ways to predict how long breast cancer patients might live without their cancer coming back, and found that one method isn't better than the other.
Methodology
The study analyzed data from 1818 operable breast cancer patients treated between 2000 and 2005, comparing the NPI and Lpi using statistical methods including the concordance index and Kaplan-Meier survival curves.
Potential Biases
The study's findings may be influenced by the specific patient population and treatment protocols at a single institution.
Limitations
The study had a relatively short follow-up time and did not include overall survival analyses.
Participant Demographics
The median age at diagnosis was 57 years, with a median of 16 lymph nodes dissected per patient.
Statistical Information
P-Value
0.2176
Confidence Interval
0.01; 0.04
Statistical Significance
p < 0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website